Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
Sign Up to like & getrecommendations! Published in 2023 at "OncoTargets and Therapy"
DOI: 10.2147/ott.s400824
Abstract: Objective Nanosomal docetaxel lipid suspension (NDLS) is a novel formulation developed to overcome toxicity issues caused by excipients (polysorbate 80 and ethanol) present in commercially available docetaxel formulation. We conducted a prospective, observational study to… read more here.
Keywords: breast cancer; conventional docetaxel; docetaxel; ndls ... See more keywords